ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate - טבליות לעיסות - calcium carbonate 500 mg - calcium carbonate - calcium carbonate - antacid, calcium supplement.

ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate - טבליות לעיסות - calcium carbonate 1000 mg - calcium carbonate - calcium carbonate - antacid, calcium supplement.

ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate - טבליות לעיסות - calcium carbonate 750 mg - calcium carbonate - calcium carbonate - treatment of heartburn, calcium supplement.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - calcitonin salmon 200 iu/dose - nasal spray - calcitonin (salmon synthetic) - fortical® nasal spray is indicated for:postmenopausal osteoporosis – fortical® calcitonin-salmon (rdna origin) nasal spray isindicated for the treatment of postmenopausal osteoporosis in women greater than 5 yearspostmenopause with low bone mass relative to healthy premenopausal women. use of fortical®calcitonin-salmon (rdna origin) nasal spray is recommended in conjunction with an adequatecalcium (at least 1000 mg elemental calcium per day) and vitamin d (400 international units perday) intake to retard the progressive loss of bone mass. the evidence of efficacy for calcitoninsalmonis based on increases in spinal bone mineral density (bmd) observed in clinical trials

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - artificial butterscotch flavor 146 mg / 100 g; artificial vanilla 1.9 g / 100 g - powder for suspension - fat/carbohydrates/proteins/minerals/vitamins, combinations - specialized elemental nutrition with glutamine for metabolically stressed patients with gastrointestinal complications.may be used as a sole source of nutrition or as a supplement to a prescribed diet.

ישראל - עברית - Ministry of Health

romat ltd - ferrous as dextran - תמיסה להזרקה - ferrous as dextran 100 mg/ml

ישראל - עברית - Ministry of Health

cure medical & technical supply - chromium chloride; copper chloride; ferric chloride; manganese chloride; potassium iodide; sodium fluoride; sodium molybdate; sodium selenite; zinc chloride - תרכיז להכנת תמיסה לאינפוזיה - copper chloride 0.34 mg/ml; potassium iodide 16.6 mcg/ml; sodium molybdate 4.85 mcg/ml; sodium selenite 6.9 mcg/ml; zinc chloride 1.36 mg/ml; chromium chloride 5.33 mcg/ml; ferric chloride 0.54 mg/ml; sodium fluoride 0.21 mg/ml; manganese chloride 99 mcg/ml - combinations of electrolytes - combinations of electrolytes - supplement in iv nutrition for adults to meet the requirements of trace elements.

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine 210 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine 300 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine as pamoate monohydrate 405 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr